[1]
Cardon, L.R.; Harris, T. Precision medicine, genomics and drug discovery. Hum. Mol. Genet., 2016, 25(R2), R166-R172. [https://doi.org/10.1093/hmg/ddw246]. [PMID: 27538422].
[2]
Chen, C.; Yang, Z.; Tang, X. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. Med. Res. Rev., 2018, 38(3), 829-869. [doi: 10.1002/med.21479].
[3]
Han, H.; Hurley, L.H. G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol. Sci., 2000, 21(4), 136-142. [doi:10.1016/s0165-6147(00)01457-7].
[4]
Biffi, G.; Tannahill, D.; McCafferty, J.; Balasubramanian, S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem., 2013, 5(3), 182-186. [doi:10.1038/nchem.1548].
[5]
Chambers, V.S.; Marsico, G.; Boutell, J.M.; Di Antonio, M.; Smith, G.P.; Balasubramanian, S. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nat. Biotechnol., 2015, 33(8), 877-881.
[6]
Estep, K.N.; Butler, T.J.; Ding, J.; Brosh, R.M. G4-interacting DNA helicases and polymerases: potential therapeutic targets. Curr. Med. Chem., 2019, 26(16), 2881-2897.